Kairos Pharma Ltd.

AMEX: KAPA · Real-Time Price · USD
1.19
-0.05 (-4.03%)
At close: Aug 15, 2025, 3:59 PM
1.22
2.68%
After-hours: Aug 15, 2025, 07:54 PM EDT

Kairos Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
160K 160K 160K 98K
Gross Profit
-160K -160K -160K -98K
Operating Income
-2.34M -1.71M -571K -1.94M
Interest Income
n/a n/a n/a n/a
Pretax Income
-2.6M -1.81M -1.05M -2.15M
Net Income
-2.6M -1.81M -1.05M -2.15M
Selling & General & Admin
1.93M 1.47M 324K 1.66M
Research & Development
414K 82K 87K 183K
Other Expenses
n/a 160K 160K 98K
Operating Expenses
2.34M 1.71M 571K 1.94M
Interest Expense
859K 98K 479K 202K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-2.34M 1.71M 571K 1.94M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
11.36M 10.38M 10.24M 12.84M
Shares Outstanding (Diluted)
11.36M 10.38M 10.24M 12.84M
EPS (Basic)
-0.23 -0.17 -0.1 -0.17
EPS (Diluted)
-0.23 -0.17 -0.1 -0.17
EBITDA
-2.34M -1.55M -431K -1.88M
EBIT
-2.64M -1.71M -591K -1.98M
Depreciation & Amortization
295K 160K 160K 98K